UC Davis researchers are advancing RNA editing, a promising approach that could enable new therapies for genetic diseases without permanently altering DNA. The foundational science has shown great promise with the National Institutes of Health has invested millions of dollars in the research.
In a study appearing in PLOS Global Public Health, UC Davis researchers investigated the epidemiological risk factors, outside of HIV, associated with TB in South Africa’s Northern Cape Province.
